Oyster Point Pharma, Inc.
Biotechnology company · Princeton, New Jersey, United States
Oyster Point Pharma, Inc. is a biotechnology company headquartered in Princeton, New Jersey, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $85 million sold in a notice filed in 2019.
Oyster Point Pharma at a glance
What does Oyster Point Pharma do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $85 million sold (2019).
Frequently asked questions about Oyster Point Pharma
Where is Oyster Point Pharma headquartered?
Oyster Point Pharma, Inc. is headquartered in Princeton, New Jersey, United States.
What does Oyster Point Pharma do?
Oyster Point Pharma, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Oyster Point Pharma founded?
The earliest incorporation on record for Oyster Point Pharma, Inc. is in 2015, according to public company registers.
Similar companies
- Optimeos Life Sciences, Inc.Princeton, New Jersey, United States
- Santiste Medical Inc.Princeton, New Jersey, United States
- Nanocan Therapeutics CorporationPrinceton, New Jersey, United States
- Regenosine, Inc.Princeton, New Jersey, United States
- Rhodenergy An Environmental Co CorpPrinceton, New Jersey, United States
- Inaedis, IncPrinceton, New Jersey, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences